Ovarian Cancer

The Pharmacy Times® Ovarian Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the group of diseases that originates in the ovaries, fallopian tubes, or the peritoneum.

Latest News

Blisters of oral contraceptive pills on pink background, flat lay | Image Credit: New Africa | stock.adobe.com
Balancing Cancer Risks and Benefits of Oral Contraceptives

July 31st 2025

Hormonal contraceptives present a nuanced risk-benefit profile, slightly increasing breast and cervical cancer risk while significantly reducing ovarian and endometrial cancer rates.

NCCN Flash Update: Ovarian Cancer Guidelines Version 3.2025 Released With Maintenance Therapy Adjustment for HR-Deficiency
NCCN Flash Update: Ovarian Cancer Guidelines Version 3.2025 Released With Maintenance Therapy Adjustment for HR-Deficiency

July 18th 2025

Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC

May 8th 2025

Ovarian cancer -- Image credit: Dr_Microbe | stock.adobe.com
INX-315 Granted FDA Fast Track Designation for Platinum-Resistant/Refractory Ovarian Cancer

May 5th 2025

Ovarian cancer -- Image credit: Lars Neumann | stock.adobe.com
CUSP06 Granted FDA Fast Track Designation for Patients With Platinum-Resistant Ovarian Cancer

February 13th 2025